These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6358039)

  • 1. Enterobacterial common antigen-tetanus toxoid conjugate as immunogen.
    Lugowski C; Kułakowska M; Romanowska E
    Infect Immun; 1983 Dec; 42(3):1086-91. PubMed ID: 6358039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of an enterobacterial common antigen (ECA) epitope recognized by anti-ECA-tetanus toxoid conjugate serum.
    Lugowski C; Romanowska E
    FEMS Microbiol Lett; 1991 Jan; 61(2-3):315-8. PubMed ID: 1709894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of enterobacterial common antigen:immunogenic and nonimmunogenic enterobacterial common antigen-containing Escherichia coli.
    Rinno J; Golecki JR; Mayer H
    J Bacteriol; 1980 Feb; 141(2):814-21. PubMed ID: 6154038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological evaluation of meningococcal group C polysaccharide-tetanus toxoid conjugate in mice.
    Beuvery EC; van Delft RW; Miedema F; Kanhai V; Nagel J
    Infect Immun; 1983 Aug; 41(2):609-17. PubMed ID: 6409811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic cross-reaction between enterobacterial common antigen and rat tissue.
    Krasny SA; Gorzynski EA
    Immunopharmacology; 1979 Dec; 2(1):1-8. PubMed ID: 553080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.
    Jennings HJ; Lugowski C
    J Immunol; 1981 Sep; 127(3):1011-8. PubMed ID: 6790606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Wessels MR; Paoletti LC; Pinel J; Kasper DL
    J Infect Dis; 1995 Apr; 171(4):879-84. PubMed ID: 7706814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus.
    Paoletti LC; Kasper DL; Michon F; DiFabio J; Holme K; Jennings HJ; Wessels MR
    J Biol Chem; 1990 Oct; 265(30):18278-83. PubMed ID: 2120228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemistry and biology of the enterobacterial common antigen (ECA).
    Mayer H; Schmidt G
    Curr Top Microbiol Immunol; 1979; 85():99-153. PubMed ID: 385250
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.
    Jennings HJ; Roy R; Gamian A
    J Immunol; 1986 Sep; 137(5):1708-13. PubMed ID: 3091688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical, toxicological and immunological consequences of the use of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as coupling reagent for the preparation of meningococcal group C polysaccharide-tetanus toxoid conjugate as vaccine for human use.
    Beuvery EC; Speijers GJ; Lutz BI; Freudenthal D; Kanhai V; Haagmans B; Derks HJ
    Dev Biol Stand; 1986; 63():117-28. PubMed ID: 3091432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic cross-reactivity between human tissues and the enterobacterial common antigen.
    Morgenstern MA; Gorzynski EA
    Infect Immun; 1977 Jul; 17(1):36-42. PubMed ID: 328395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of enterobacterial common antigen by bacterial agglutination.
    Marx A; Petcovici M; Nacescu N; Mayer H; Schmidt G
    Infect Immun; 1977 Dec; 18(3):563-7. PubMed ID: 338482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmonella typhi O-polysaccharide--tetanus toxoid conjugated vaccine.
    Saxena M; Di Fabio JL
    Vaccine; 1994 Aug; 12(10):879-84. PubMed ID: 7526567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The immunogenic and antigenic properties of the individual fractions of tetanus anatoxin].
    Runova VF; Kargina TM; Selezneva VP
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):75-6. PubMed ID: 7879554
    [No Abstract]   [Full Text] [Related]  

  • 16. Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.
    Paoletti LC; Wessels MR; Michon F; DiFabio J; Jennings HJ; Kasper DL
    Infect Immun; 1992 Oct; 60(10):4009-14. PubMed ID: 1398913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of two types of meningococcal group C polysaccharide conjugates using tetanus toxoid as carrier protein.
    Beuvery EC; Roy R; Kanhai V; Jennings HJ
    Dev Biol Stand; 1986; 65():197-204. PubMed ID: 3104115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological activities of purified preparations of enterobacterial common antigen.
    Gannon PJ; Jacobs DM; Marx A; Mayer H; Romanowska E; Neter E
    Infect Immun; 1982 Jan; 35(1):193-201. PubMed ID: 7033134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of children born to women immunized with tetanus toxoid during pregnancy.
    Gill TJ; Karasic RB; Antoncic J; Rabin BS
    Am J Reprod Immunol; 1991 Mar; 25(2):69-71. PubMed ID: 1872953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific IgA subclass responses in serum and saliva: a 12-month follow-up study after parenteral booster immunization with tetanus toxoid.
    Engström PE; Gustafson R; Granberg M; Engström GN
    Acta Odontol Scand; 2002 Aug; 60(4):198-202. PubMed ID: 12222642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.